Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Ask the chart: “Has this stock recovered from similar drawdowns before?”
AI equity note (bull/bear, numbers, sources) — coming soon
Management guidance consistency — coming soon
Latest filings
NSE announcements · newest firstSchedule of meet
Credit Rating- Revision
Other Restructuring - Rationalisation and Consolidation of Company''s Step-down Subsidiaries in the Philippines as per the disclosure annexed herewith.
Nephrocare Health Services Limited has informed the Exchange about Agreements
Key MetricsFull financials →
P/E (TTM)
–
P / Book
6.26×
BVPS ₹111
ROE
6.9%
FY26, avg equity
Net margin
7.7%
FY26
Revenue YoY
–
Q1 FY27
Net profit YoY
–
Q1 FY27
Debt / equity
0.07×
₹80 Cr debt
Div. yield
–
no dividend in 12 months
From NSE filings (consolidated) and the last close.
Shareholding Pattern Jun 2026
Promoter pledge: none reported
Peer Comparison
| Company | P/E | P/B | ROE | Margin |
|---|---|---|---|---|
| VIJAYA₹15,574 Cr | 83.1× | 16.27× | 19.7% | 21.2% |
| METROPOLIS₹12,079 Cr | 59.6× | 7.98× | 13.4% | 11.6% |
| THYROCARE₹9,023 Cr | 51.3× | 15.41× | 28.8% | 19.6% |
| NEPHROPLUS₹6,990 Cr | – | 6.26× | 6.9% | 7.7% |
| SURAKSHA₹1,788 Cr | 49.7× | 7.30× | 13.8% | 10.1% |
| KRSNAA₹1,779 Cr | 18.3× | 1.81× | 10.9% | 13.1% |
Healthcare Service Provider: the companies closest in market value, of the 9 in that basic industry whose filings we hold. Computed from each company's NSE filings (up to Q1 FY27) and the last close; hover a column for its definition.
Forensic Flags
Profit before interest and tax covers finance costs 2.7×
FY26.
Other income is 24% of profit before tax
FY26.
4 checks within their thresholds
Debt to equity is 0.07×
As at 2026-03-31.
No promoter shares are pledged
Shareholding pattern as at 2026-06-30.
No auditor change or resignation filings in three years
From NSE announcements on record.
Results were filed late in 0 of the last 3 quarters
Slowest filing came 49 days after the period end.
Computed from NSE filings (consolidated). Colours follow fixed thresholds, shown on hover. These are facts about the filings, not advice. 3 checks not run for lack of data.
Formula Scores
Piotroski F-score: not computed · FY to 2026-03-31needs two years of results and both years' balance sheets
Altman Z-score: 15.18 · FY to 2026-03-31Z = 1.2 × working capital / total assets + 1.4 × retained earnings / total assets + 3.3 × EBIT / total assets + 0.6 × market value of equity / total liabilities + 1.0 × sales / total assets
- working capital / total assets: 0.367 × 1.2
- retained earnings / total assets: 0.745 × 1.4 — reserves and surplus as retained earnings
- EBIT / total assets: 0.109 × 3.3 — profit before tax plus finance cost
- market value of equity / total liabilities: 21.087 × 0.6 — market capitalisation over total assets less equity
- sales / total assets: 0.679 × 1
Inputs: total assets ₹1,471 Cr (2026-03-31) · current assets ₹839 Cr (2026-03-31) · current liabilities ₹299 Cr (2026-03-31) · reserves ₹1,096 Cr (2026-03-31) · total equity ₹1,116 Cr (2026-03-31) · profit before tax ₹101 Cr (2026-03-31) · finance cost ₹60 Cr (2026-03-31) · revenue ₹999 Cr (2026-03-31) · market capitalisation (today) ₹7,473 Cr
The paper's bands: above 2.99: the paper's safe zone; 1.81–2.99: the grey zone; below 1.81: the distress zone
the 1968 form, fitted on manufacturers; reserves stand in for retained earnings, and profit before tax plus finance cost for EBIT
Source: Edward Altman, "Financial Ratios, Discriminant Analysis and the Prediction of Corporate Bankruptcy", Journal of Finance, 1968
Graham number: 142.4 ₹ per share · FY to 2026-03-31√(22.5 × earnings per share × book value per share): the price at which P/E × P/B = 22.5 (a P/E of 15 at a P/B of 1.5)
- earnings per share: 8.1
- book value per share: 111.27 — owners' equity over shares (paid-up capital / face value)
Inputs: earnings per share 8.1 (2026-03-31) · owners' equity ₹1,116 Cr (2026-03-31) · paid-up capital ₹20 Cr (2026-03-31) · face value 2 (2026-03-31)
a number the book uses as a ceiling for a defensive investor's purchase price; it is arithmetic on two reported figures, not a valuation
Source: Benjamin Graham, The Intelligent Investor (1949; the 22.5 in the 1973 edition's criteria for the defensive investor)
Sloan accrual ratio: -10.59 % of assets · FY to 2026-03-31(profit after tax − operating cash flow) / average total assets
Inputs: profit after tax ₹77 Cr (2026-03-31) · operating cash flow ₹233 Cr (2026-03-31) · total assets ₹1,471 Cr (2026-03-31)
how much of the year's profit was not cash; the paper sorts companies by this and reports the top decile's later returns
Source: Richard Sloan, "Do Stock Prices Fully Reflect Information in Accruals and Cash Flows about Future Earnings?", The Accounting Review, 1996
Each score is its published formula applied to the company's own filings (consolidated); open one for the tests, the inputs and the paper. Arithmetic on the filings, not a view on the stock.